November 1, 2024
Retinal Vein Occlusion Articles
October 1, 2024
Clinical Trial Update October 2024
September 1, 2024
Clinical Trial Update September 2024
July 1, 2024
Clinical Trial Update July/August 2024
June 1, 2024
Clinical Trial Update June 2024
May 1, 2024
Clinical Trial Update May 2024
March 1, 2024
Clinical Trial Update March 2024
February 16, 2024
Retinal Physician eUpdate - February 16, 2024
By Steve Lenier
January 1, 2024
Subspecialty News January/February 2024
By Rochelle Nataloni, contributing writer
January 1, 2024
Clinical Trial Update January/February 2024
January 1, 2024
Breaking News: 12-month Data for Faricimab for Retinal Vein Occlusion
By Ramin Tadayoni, MD, PhD, Michael A. Singer, MD
November 1, 2023
Clinical Trial Update November/December 2023
September 1, 2023
Bispecific Antibodies in Retina Therapies
By René Rückert, MD, MBA, Gemmy Cheung Chui Ming, FRCOphth, Marion R. Munk, MD, PhD, FEBO
September 1, 2023
Clinical Trial Update September 2023
July 1, 2023
Clinical Trial Update July/August 2023
June 1, 2023
Clinical Trial Update June 2023
May 1, 2023
Clinical Trial Update May 2023
April 1, 2023
Clinical Trial Update April 2023
March 1, 2023
Clinical Trial Update March 2023
February 1, 2023
Clinical Trial Update: Special Edition 2023
January 1, 2023
Clinical Trial Update January/February 2023
November 1, 2022
Clinical Trial Update November/December 2022
October 1, 2022
Clinical Trial Update October 2022
September 1, 2022
Clinical Trial Update September 2022
August 1, 2022
Clinical Trial Update Special Edition 2022
July 1, 2022
Clinical Trial Update July/August 2022
June 1, 2022
SUBSPECIALTY NEWS: Geographic atrophy quality-of-life survey, Xipere launch, ophthalmic bevacizumab FDA application, and more.
By Rochelle Nataloni, contributing writer
June 1, 2022
Clinical Trial Update June 2022
May 1, 2022
Clinical Trials in Retinal Vein Occlusion
By Neesurg Mehta, MD, Susanna S. Park, MD, PhD
May 1, 2022
Clinical Trial Update May 2022
April 1, 2022
Clinical Trial Update April 2022
March 1, 2022
SUBSPECIALTY NEWS: Results in suprachoroidal trial, RNA therapy for RP, Beovu in DME, and more.
By Rochelle Nataloni, contributing writer
March 1, 2022
Clinical Trial Update March 2022
January 1, 2022
Clinical Trial Update January/February 2022
Advertisement
Recommendations
Advertisement